Concise Report

Aim To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. Methods A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered ‘never’ or ‘not very often’, they were asked whether they would change their practice according to the particular recommendation. Results A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were ‘always’ and ‘very often’. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. Conclusion The results of this survey demonstrated great support of ‘Treating RA to Target’ recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice.

[1]  C. Bombardier,et al.  Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs , 2012, The Journal of Rheumatology.

[2]  John Wong,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.

[3]  D. Lackland,et al.  Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. , 2003, Archives of internal medicine.

[4]  B. Dijkmans,et al.  Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. , 2006, Clinical and experimental rheumatology.

[5]  T. Pearson The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease. , 2004, The American journal of cardiology.

[6]  P. Tugwell,et al.  American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. , 2011, Arthritis and rheumatism.

[7]  V. Bykerk,et al.  Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population? , 2008, The Journal of rheumatology.

[8]  P. Nilsson,et al.  Glycemic and Risk Factor Control in Type 1 Diabetes , 2007, Diabetes Care.

[9]  T. Pincus,et al.  A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. , 2007, Best practice & research. Clinical rheumatology.

[10]  M. Dougados,et al.  Extended report: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search , 2010 .

[11]  A. McMahon,et al.  Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial , 2004, The Lancet.

[12]  J. A. Rindfleisch,et al.  Diagnosis and management of rheumatoid arthritis. , 2005, American family physician.

[13]  M. Ravid,et al.  Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  Maurizio Cutolo,et al.  Treating rheumatoid arthritis to target: recommendations of an international task force , 2010, Annals of the rheumatic diseases.